COMMENT: The new craze of using lower-than-recommended dosages of weight loss drugs to slim down might sound tempting, says ...

Used sharps, including hypodermic needles for medical injections, require safe storage in an FDA-cleared container made of ...

FDA ends GLP-1 drug shortage. Concerns over safety, counterfeit drugs, and high cost of brand-name versions persist; ...

Bank of New York Mellon Corp increased its holdings in Embecta Corp. (NASDAQ:EMBC – Free Report) by 0.7% in the 4th quarter, ...

Novo Nordisk’s semaglutide diabetes and weight loss drugs, Ozempic and Wegovy, are no longer officially in shortage in the US ...

At 44, Chris Wallace started balding. Then he traveled to Istanbul, the hair transplant capital of the world. This story is ...

AstraZeneca and Ionis Pharmaceuticals’ polyneuropathy drug has won approval in the European Union (EU), where it will be ...

AstraZeneca and Ionis Pharma have an EU green light for their Wainzua therapy for hereditary transthyretin-mediated ...

Oppenheimer Asset Management Inc. purchased a new stake in Embecta Corp. (NASDAQ:EMBC – Free Report) in the fourth quarter, Holdings Channel.com reports. The institutional investor purchased 10,097 ...

The biotech will commit $150 million to an alliance that hands it significant production capacity for a closely watched ...

In today’s evolving pharmaceutical environment, the fill‐finish segment stands out as a critical linchpin connecting drug ...